Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey
- First Online:
- 326 Downloads
The aim of this study was to determine the prevalence and pattern of unlicensed and off-label drugs prescribed to hospitalized children at the Department of Paediatrics, University Hospital Rijeka, Croatia.
A prospective cross-sectional study was performed on 1 day each month during a 12 month period and included all hospitalized children and adolescents.
A total of 1,643 prescriptions for 198 different drugs were prescribed to 531 out of 691 (77%) hospitalized patients. Forty-six percent of the different drugs were prescribed in an unlicensed or off-label manner. Of all drug prescriptions, 25% were either unlicensed or off-label. Forty-eight percent of the patients received either an unlicensed or off-label drug. The most frequently prescribed off-label drugs were proton pump inhibitors.
Unlicensed and off-label drug use is common. It is not illegal and may be clinically appropriate but is associated with a number of clinical, safety, and ethical issues. Regulatory authorities should use existing clinical evidence on the use of off-label and unlicensed drugs in decision making. Marketing authorization holders and national regulatory authorities should monitor for any safety concerns associated with unlicensed and off-label drug use and take appropriate measures as well as identify research priorities and mandate clinical studies to resolve important questions.
KeywordsChildren Drug prescribing Unlicensed Off-label
- 10.Tafuri G, Trotta F, Leufkens HGM, Martini N, Sagliocca L, Traversa G (2009) Off-label use of medicines in children: can available evidence avoid useless paediatric clinical trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease. Eur J Clin Pharmacol 65:209–216PubMedCrossRefGoogle Scholar
- 12.EC (2006) Regulation (EC) No 1901/2006 of 12 December 2006on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004.http://ec.europa.eu/health/files/eudralex/vol-1/reg_2006_1901/reg_2006_1901_en.pdf . Accessed 26 August 2011